CVR number 27508723
Industry 46.4220 Wholesale of clothing and footwear

NEW FEET MEDICAL FOOTWEAR A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  2.8% 2.8% 2.8% 2.8% 2.8%  
Bankruptcy risk  1.2% 1.7% 1.6% 1.2% 1.2%  
Credit score (0-100)  81 71 74 80 83  
Credit rating  A A A A A  
Credit limit (kDKK)  422.1 13.1 29.0 214.1 311.6  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  13,519 12,501 15,035 13,668 13,703  
EBITDA  5,991 3,730 5,059 3,722 4,517  
EBIT  5,636 3,445 4,552 3,147 4,066  
Pre-tax profit (PTP)  5,698.7 3,811.8 4,618.1 3,111.0 3,377.9  
Net earnings  4,414.8 2,878.7 3,540.6 2,400.4 2,600.6  
Pre-tax profit without non-rec. items  5,699 3,812 4,618 3,111 3,378  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  20,233 1,265 1,407 868 1,566  
Shareholders equity total  13,949 6,621 7,277 6,115 6,311  
Interest-bearing liabilities  11,334 3,218 3,048 9,033 5,966  
Balance sheet total (assets)  35,052 21,215 19,100 20,609 17,834  
Net Debt  8,240 -4,892 1,909 6,768 4,860  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  13,519 12,501 15,035 13,668 13,703  
Gross profit growth  16.5% -7.5% 20.3% -9.1% 0.3%  
Employees  15 16 16 16 14  
Employee growth %  15.4% 6.7% 0.0% 0.0% -12.5%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  35,052 21,215 19,100 20,609 17,834  
Balance sheet change%  11.9% -39.5% -10.0% 7.9% -13.5%  
Added value  5,991.2 3,729.9 5,058.7 3,654.2 4,516.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -403 -19,203 -371 -1,119 242  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  41.7% 27.6% 30.3% 23.0% 29.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  18.7% 14.3% 25.5% 20.1% 23.6%  
ROI %  23.6% 22.3% 49.5% 30.2% 31.8%  
ROE %  29.0% 28.0% 50.9% 35.8% 41.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  41.1% 31.3% 38.2% 29.8% 35.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  137.5% -131.2% 37.7% 181.8% 107.6%  
Gearing %  81.3% 48.6% 41.9% 147.7% 94.5%  
Net interest  0 0 0 0 0  
Financing costs %  4.9% 3.1% 16.6% 14.6% 15.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.9 0.9 0.6 0.6 0.6  
Current Ratio  1.5 1.3 1.5 1.3 1.4  
Cash and cash equivalent  3,094.0 8,110.3 1,139.8 2,265.7 1,105.6  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  5,084.4 4,450.2 5,416.7 4,810.8 4,404.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  399 233 316 228 323  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  399 233 316 233 323  
EBIT / employee  376 215 284 197 290  
Net earnings / employee  294 180 221 150 186